Patient care quality is a discipline that has acquired enormous relevance in today’s healthcare. Quality Oncology Practice Initiative (QOPI) is a referral worldwide in terms of quality for oncology practices. ECO Foundation is a platform of experts representing the major Spanish hospitals involved in the treatment of cancer patients. ECO reached an agreement with QOPI to involve Spanish hospitals in the QOPI program.
Five rounds of data collection have taken place (Fall 2015 to Fall 2017). Practices had to register online and submit data into the QOPI platform. ECO Foundation offers all centres the necessary support. 16 Spanish hospitals have participated in the five rounds. 7 of them have repeated participation. Core and Lung Cancer modules were completed.
During the five rounds, 1745 charts were submitted by the Spanish practices. In the majority of the rounds, the highest scores were: Pathology report confirming malignancy, Number of chemotherapy cycles documented, Patient consent for chemotherapy and 5 measures of the Lung Cancer module. The lowest scores were: Chemotherapy treatment summary provided to patient within 3 months of chemotherapy end, Chemotherapy treatment summary provided or communicated to practitioner(s) within 3 months of chemotherapy end, Smoking/tobacco use cessation counselling recommended to smokers/tobacco users in past year and Tobacco cessation counselling administered or patient referred in past year. The percentage of participating practices that presented results higher than 70% was successively 64%, 50%, 75% and 100% in the last two rounds. For the 7 hospitals that repeated participation, 3 reported an improvement of their global scores. Regarding QOPI Certification, three Spanish hospitals received this accreditation in September 2017.
These preliminary results are a good starting point for the continued implementation of the QOPI program in Spain, thus providing a well-structured approach to analyse cancer care. ECO Foundation will continue pursuing excellence and quality with further activities like the QOPI Certification program and Quality Training Program, these being performed for the first time in Spain in 2017 and 2018 respectively.
Clinical trial identification
Legal entity responsible for the study
Mundipharma, Bristol-Myers Squibb, Novartis.
All authors have declared no conflicts of interest.